Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Federica Esposito; Laura Ferrè; Ferdinando Clarelli; Maria A. Rocca; Giacomo Sferruzza; Loredana Storelli; Marta Radaelli; Francesca Sangalli; Lucia Moiola; Bruno Colombo; Filippo Martinelli Boneschi; Gıancarlo Comı; Massimo Filippi; Vittorio Martinelli

doi:10.1007/s00415-018-8791-1

Related publications

Article2021

Genetic factors implicated in the response to fingolimod treatment in multiple sclerosis patients: results from a pharmacogenetic meta-analysis

Laura Ferrè, Elisabetta Mascia, Ferdinando Clarelli, Tina Roostaei, Béatrice Pignolet, David Brassat, Roland Liblau, Howard L. Weiner, Philip L. De Jager, Massimo Filippi, Federica Esposito

Article2023

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)

Clara Grazia Chisari, Assunta Bianco, Vincenzo Brescia Morra, Massimiliano Calabrese, Fioravante Capone, Paola Cavalla, Carlotta Chiavazza, Cristoforo Comi, Maura Danni, Massimo Filippi, Pietro Iaffaldano, Roberta Lanzillo, Salvatore Lo Fermo, Alessandra Lucisano, Alessandra Lugaresi, Giacomo Lus, Gerolama Alessandra Marfia, Fabiana Marinelli, Massimiliano Mirabella, Lucia Moiola, Chiara Perin, Sabrina Realmuto, Simona Toscano, María Trojano, Domizia Vecchio, Francesco Patti

Preprint2023

Effectiveness of Ocrelizumab in Primary PrOgRessive mulTiple sclerosis: a mUlticeNter, retrospective, real-world sTudY (OPPORTUNITY)

Clara Grazia, Assunta Bianco, Vincenzo Brescia Morra, Massimiliano Calabrese, Fioravante Capone, Paola Cavalla, Cristoforo Comi, Maura Danni, Massimo Filippi, Pietro Iaffaldano, Roberta Lanzillo, Salvatore Lo Fermo, Alessandra Lucisano, Giacomo Lus, Gerolama Alessandra Marfia, Fabiana Marinelli, Massimiliano Mirabella, Chiara Perin, Lucia Moiola, Sabrina Realmuto, Simona Toscano, María Trojano,

Article2023

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

Serena Ruggieri, Luca Prosperini, Sarmad Al‐Araji, Pietro Annovazzi, Alvino Bisecco, Olga Ciccarelli, Nicola De Stefano, Massimo Filippi, Vinzenz Fleischer, Nikos Evangelou, Christian Enzinger, Antonio Gallo, Afagh Garjani, Sergiu Groppa, Shalom Haggiag, Michael Khalil, Matteo Lucchini, Massimiliano Mirabella, Xavier Montalbán, Carlo Pozzilli, Paolo Preziosa, Jordi Río, Maria A. Rocca,

Article2021

Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience

Sara Guerrieri, Serena Marita Lazzarin, Chiara Zanetta, Agostino Nozzolillo, Massimo Filippi, Lucia Moiola